Summary
- Current Price
- As of today, ANRO price is $28.67, up +0.70% on
- Current Price All-Time High
- ANRO price is currently -2.78% below its historical high of $29.49 set on
- Market Cap
- ANRO current market cap is $1B, up +1245.25% over the past 365 days
- Revenue
- ANRO current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for ANRO is on
Profile
| Metric | Value |
|---|---|
| Full Name | Alto Neuroscience, Inc. |
| Ticker | NYSE: ANRO |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | altoneuroscience.com |
| Employees | 68 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $28.67 | |
| Price, 1D Change | +0.70% | |
| $1B | ||
| - | ||
| - | ||
| 2.28 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.19 | ||
| EPS, 1Y Change | +12.22% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.19 | ||
| EPS Estimate | -$3.15 | N/A |
| EPS Est. Change | -43.49% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $28.67 | |
| Price Target | $35.00 | - |
| Price Tgt. Change | +22.08% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.60 | -$2.50 | +3.84% | |
| -$2.25 | -$2.19 | +2.54% | |
| -$3.15 | N/A | -43.49% | |
| -$3.43 | N/A | -56.64% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $28.67 | |
| $20.08 | ||
| $24.73 | ||
| $19.99 | ||
| $25.73 | ||
| $0.82 | ||
| 2.28 | ||
| $1.86 | ||
| 59.36 | ||
| 57.32% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$2.19 | ||
| -$661.00K | ||
| - | ||
| -$66.36M | ||
| - | ||
| -$63.24M | ||
| - | ||
| -$65.70M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.16 | ||
| 15.69 | ||
| 15.69 | ||
| - | ||
| - | ||
| 18.30 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 4.58 | ||
| -11.32 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $151.14M | ||
| $176.48M | ||
| $184.69M | ||
| $177.72M | ||
| $33.55M | ||
| $11.33M | ||
| $23.96M | ||
| $1.74M | ||
| $1.88M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $63.24M | ||
| $65.70M | ||
| $661.00K | ||
| $0.00 | ||
| $661.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$51.77M | ||
| -$24.00K | ||
| $60.08M | ||
| $24.00K | ||
| -$51.79M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Baird | → | |
| Wedbush | → | |
| HC Wainwright& Co. | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| Wedbush | → | |
| Jones Trading | → | |
| HC Wainwright & Co. | → | |
| Chardan Capital | → | |
| Baird | → |
Analyst sentiment
Institutional ownership
Screeners with ANRO
FAQ
- What is the ticker symbol for Alto Neuroscience, Inc.?
- The ticker symbol for Alto Neuroscience, Inc. is NYSE:ANRO
- Does Alto Neuroscience, Inc. pay dividends?
- No, Alto Neuroscience, Inc. does not pay dividends
- What sector is Alto Neuroscience, Inc. in?
- Alto Neuroscience, Inc. is in the Healthcare sector
- What industry is Alto Neuroscience, Inc. in?
- Alto Neuroscience, Inc. is in the Biotechnology industry
- What country is Alto Neuroscience, Inc. based in?
- Alto Neuroscience, Inc. is headquartered in United States
- When did Alto Neuroscience, Inc. go public?
- Alto Neuroscience, Inc. initial public offering (IPO) was on February 2, 2024
- Is Alto Neuroscience, Inc. in the S&P 500?
- No, Alto Neuroscience, Inc. is not included in the S&P 500 index
- Is Alto Neuroscience, Inc. in the NASDAQ 100?
- No, Alto Neuroscience, Inc. is not included in the NASDAQ 100 index
- Is Alto Neuroscience, Inc. in the Dow Jones?
- No, Alto Neuroscience, Inc. is not included in the Dow Jones index
- When was Alto Neuroscience, Inc. last earnings report?
- Alto Neuroscience, Inc.'s most recent earnings report was on May 13, 2026
- When does Alto Neuroscience, Inc. report earnings?
- The next expected earnings date for Alto Neuroscience, Inc. is August 12, 2026
Data Sources & References
- ANRO Official Website www.altoneuroscience.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1999480/000199948026000002/0001999480-26-000002-index.htm
- ANRO Profile on Yahoo Finance finance.yahoo.com/quote/ANRO
- ANRO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/anro